Highlights
The global Nano-based Drug Delivery System market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Nano-based Drug Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Nano-based Drug Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Nano-based Drug Delivery System in Hydrophilic Drugs is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Nano-based Drug Delivery System include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nano-based Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nano-based Drug Delivery System.
The Nano-based Drug Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nano-based Drug Delivery System market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nano-based Drug Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Segment by Type
Less than 50nm
50-150nm
150-300nm
Others
Segment by Application
Hydrophilic Drugs
Hydrophobic Drugs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nano-based Drug Delivery System companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nano-based Drug Delivery System Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Less than 50nm
1.2.3 50-150nm
1.2.4 150-300nm
1.2.5 Others
1.3 Market by Application
1.3.1 Global Nano-based Drug Delivery System Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hydrophilic Drugs
1.3.3 Hydrophobic Drugs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nano-based Drug Delivery System Market Perspective (2018-2029)
2.2 Nano-based Drug Delivery System Growth Trends by Region
2.2.1 Global Nano-based Drug Delivery System Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nano-based Drug Delivery System Historic Market Size by Region (2018-2023)
2.2.3 Nano-based Drug Delivery System Forecasted Market Size by Region (2024-2029)
2.3 Nano-based Drug Delivery System Market Dynamics
2.3.1 Nano-based Drug Delivery System Industry Trends
2.3.2 Nano-based Drug Delivery System Market Drivers
2.3.3 Nano-based Drug Delivery System Market Challenges
2.3.4 Nano-based Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nano-based Drug Delivery System Players by Revenue
3.1.1 Global Top Nano-based Drug Delivery System Players by Revenue (2018-2023)
3.1.2 Global Nano-based Drug Delivery System Revenue Market Share by Players (2018-2023)
3.2 Global Nano-based Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nano-based Drug Delivery System Revenue
3.4 Global Nano-based Drug Delivery System Market Concentration Ratio
3.4.1 Global Nano-based Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nano-based Drug Delivery System Revenue in 2022
3.5 Nano-based Drug Delivery System Key Players Head office and Area Served
3.6 Key Players Nano-based Drug Delivery System Product Solution and Service
3.7 Date of Enter into Nano-based Drug Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nano-based Drug Delivery System Breakdown Data by Type
4.1 Global Nano-based Drug Delivery System Historic Market Size by Type (2018-2023)
4.2 Global Nano-based Drug Delivery System Forecasted Market Size by Type (2024-2029)
5 Nano-based Drug Delivery System Breakdown Data by Application
5.1 Global Nano-based Drug Delivery System Historic Market Size by Application (2018-2023)
5.2 Global Nano-based Drug Delivery System Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nano-based Drug Delivery System Market Size (2018-2029)
6.2 North America Nano-based Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Nano-based Drug Delivery System Market Size by Country (2018-2023)
6.4 North America Nano-based Drug Delivery System Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nano-based Drug Delivery System Market Size (2018-2029)
7.2 Europe Nano-based Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Nano-based Drug Delivery System Market Size by Country (2018-2023)
7.4 Europe Nano-based Drug Delivery System Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nano-based Drug Delivery System Market Size (2018-2029)
8.2 Asia-Pacific Nano-based Drug Delivery System Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Nano-based Drug Delivery System Market Size by Region (2018-2023)
8.4 Asia-Pacific Nano-based Drug Delivery System Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nano-based Drug Delivery System Market Size (2018-2029)
9.2 Latin America Nano-based Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Nano-based Drug Delivery System Market Size by Country (2018-2023)
9.4 Latin America Nano-based Drug Delivery System Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nano-based Drug Delivery System Market Size (2018-2029)
10.2 Middle East & Africa Nano-based Drug Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2018-2023)
10.4 Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Nano-based Drug Delivery System Introduction
11.1.4 Amgen Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Nano-based Drug Delivery System Introduction
11.2.4 Teva Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.2.5 Teva Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Nano-based Drug Delivery System Introduction
11.3.4 Roche Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.3.5 Roche Recent Development
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Detail
11.4.2 UCB (Union Chimique Belge) Business Overview
11.4.3 UCB (Union Chimique Belge) Nano-based Drug Delivery System Introduction
11.4.4 UCB (Union Chimique Belge) Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.4.5 UCB (Union Chimique Belge) Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Nano-based Drug Delivery System Introduction
11.5.4 Celgene Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.5.5 Celgene Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Nano-based Drug Delivery System Introduction
11.6.4 Merck Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.6.5 Merck Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Detail
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Nano-based Drug Delivery System Introduction
11.7.4 Gilead Sciences Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.7.5 Gilead Sciences Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Nano-based Drug Delivery System Introduction
11.8.4 Sanofi Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.8.5 Sanofi Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nano-based Drug Delivery System Introduction
11.9.4 Pfizer Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Nano-based Drug Delivery System Introduction
11.10.4 Takeda Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.10.5 Takeda Recent Development
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Detail
11.11.2 Bausch&Lomb Business Overview
11.11.3 Bausch&Lomb Nano-based Drug Delivery System Introduction
11.11.4 Bausch&Lomb Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.11.5 Bausch&Lomb Recent Development
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Detail
11.12.2 Samyang Biopharmaceuticals Business Overview
11.12.3 Samyang Biopharmaceuticals Nano-based Drug Delivery System Introduction
11.12.4 Samyang Biopharmaceuticals Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.12.5 Samyang Biopharmaceuticals Recent Development
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Detail
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Nano-based Drug Delivery System Introduction
11.13.4 Johnson & Johnson Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.13.5 Johnson & Johnson Recent Development
11.14 TOLMAR
11.14.1 TOLMAR Company Detail
11.14.2 TOLMAR Business Overview
11.14.3 TOLMAR Nano-based Drug Delivery System Introduction
11.14.4 TOLMAR Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.14.5 TOLMAR Recent Development
11.15 Astellas
11.15.1 Astellas Company Detail
11.15.2 Astellas Business Overview
11.15.3 Astellas Nano-based Drug Delivery System Introduction
11.15.4 Astellas Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.15.5 Astellas Recent Development
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Detail
11.16.2 AMAG Pharmaceuticals Business Overview
11.16.3 AMAG Pharmaceuticals Nano-based Drug Delivery System Introduction
11.16.4 AMAG Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.16.5 AMAG Pharmaceuticals Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Detail
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Nano-based Drug Delivery System Introduction
11.17.4 AbbVie Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.17.5 AbbVie Recent Development
11.18 Dr Reddy
11.18.1 Dr Reddy Company Detail
11.18.2 Dr Reddy Business Overview
11.18.3 Dr Reddy Nano-based Drug Delivery System Introduction
11.18.4 Dr Reddy Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.18.5 Dr Reddy Recent Development
11.19 AstraZeneca
11.19.1 AstraZeneca Company Detail
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca Nano-based Drug Delivery System Introduction
11.19.4 AstraZeneca Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.19.5 AstraZeneca Recent Development
11.20 Aspen
11.20.1 Aspen Company Detail
11.20.2 Aspen Business Overview
11.20.3 Aspen Nano-based Drug Delivery System Introduction
11.20.4 Aspen Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.20.5 Aspen Recent Development
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Detail
11.21.2 Acrotech Biopharma Business Overview
11.21.3 Acrotech Biopharma Nano-based Drug Delivery System Introduction
11.21.4 Acrotech Biopharma Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.21.5 Acrotech Biopharma Recent Development
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Detail
11.22.2 TWi Pharmaceuticals Business Overview
11.22.3 TWi Pharmaceuticals Nano-based Drug Delivery System Introduction
11.22.4 TWi Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2018-2023)
11.22.5 TWi Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
听
听
*If Applicable.
